TY  - JOUR
AU  - Hatanaka, Takeshi
AU  - Naganuma, Atsushi
AU  - Yata, Yutaka
AU  - Kakizaki, Satoru
PY  - 2022
TI  - Atezolizumab plus bevacizumab and tremelimumab plus durvalumab: how should we choose these two immunotherapy regimens for advanced hepatocellular carcinoma?
JF  - Hepatobiliary Surgery and Nutrition; Vol 11, No 6 (December 01, 2022): Hepatobiliary Surgery and Nutrition
Y2  - 2022
KW  - 
N2  - 
UR  - https://hbsn.amegroups.org/article/view/104617